olmesartan medoxomil 5 MG Oral Tablet
olmesartan medoxomil
RxCUI: 349373
What the CMS Formulary Data Shows for olmesartan medoxomil 5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, olmesartan medoxomil 5 MG Oral Tablet (RxNorm concept RXCUI 349373, generic name olmesartan medoxomil) appears on 325 distinct formulary files spanning 4,940 Medicare Part D plan offerings - 97.5% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.3.
Real-world access to olmesartan medoxomil 5 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 47.1% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 773,533 Part D beneficiaries filled olmesartan medoxomil 5 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $89,208,961 and an average per-beneficiary annual cost of $115.33. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry olmesartan medoxomil 5 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 325
- Plans covering
- 4,940
- Coverage rate
- 97.5%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 47.1% of formularies
2023 Medicare Spending
- Beneficiaries
- 773,533
- Total spending
- $89,208,961
- Avg per beneficiary
- $115.33
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering olmesartan medoxomil 5 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is olmesartan medoxomil 5 MG Oral Tablet covered by Medicare Part D?
Yes, olmesartan medoxomil 5 MG Oral Tablet is covered by 4,940 Medicare Part D plans (97.5% of all Part D formularies).
What tier is olmesartan medoxomil 5 MG Oral Tablet on Medicare Part D plans?
olmesartan medoxomil 5 MG Oral Tablet averages Tier 2.3 across Part D plans, ranging from Tier 1 to Tier 6.
Does olmesartan medoxomil 5 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for olmesartan medoxomil 5 MG Oral Tablet. Step therapy: 0%. Quantity limits: 47.1%.
How much does Medicare spend on olmesartan medoxomil 5 MG Oral Tablet?
In 2023, total Medicare Part D spending on olmesartan medoxomil 5 MG Oral Tablet was $89,208,961, covering 773,533 beneficiaries. The average spend per beneficiary was $115.33.
Read our methodology - how this data is sourced, computed, and verified.